TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Connecticut Investigators

Barbara Fussell, RN

Institute for Neurodegenerative Disorders

New haven, Connecticut - 06510 (203 401 4362)
  • SINCE2003
Evaluation of [123I]MNI-420 and Single Photon Emission Computed Tomography (SPECT) as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease (PD) and Huntington Disease (HD)

July 2009 - July 2010
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558

September 2010 - February 2011
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease

May 2003 - January 2013
Study to Identify Clinical Imaging and Biologic Markers of Parkinson Disease Progression

June 2010 - December 2017
A PET Brain Imaging Study of mGluR5 in Subjects With PD HD FXS & ASD

March 2009 - March 2011
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

March 2010 - November 2010
Alzheimer Disease

Parkinson Disease

Autistic Disorder

Child Development Disorders, Pervasive

Huntington Disease

Parkinsonian Disorders

Disease Progression

Fragile X Syndrome


[18f] Mni-558

Automated Neuropsychological Assessment Matrix


Drug: [18f] Pbr111

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo